PLATELET AGGREGATION DEVICES MARKET ANALYSIS

Platelet Aggregation Devices Market, By Product (Systems, Reagents, Consumables and Accessories), By Application (Clinical and Research), By End User (Hospitals, Diagnostic Laboratories, and Others (Research Institutes, etc.)), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In February 2023, Terumo Corporation, a healthcare company, announced the launch of IMUGARD WB Platelet Pooling Set, which extends the shelf life of whole blood-derived platelets from five days to seven days. This is the first platelet pooling set approved for seven-day storage in the U.S., providing an alternative source of platelet supply amid increasing demand and challenges in blood donation.
In May 2022, Precision BioLogic, a life science company, launched its CRYOcheck Chromogenic Factor IX assay for monitoring hemophilia B across Europe, the U.K., Australia, Canada, and New Zealand after receiving regulatory approvals. This assay offers a wide testing range, user-friendly design, and compatibility with automated analyzers, significantly enhancing the capabilities for hemophilia testing in these regions.